401 related articles for article (PubMed ID: 26094771)
21. Structure, function, and inhibition of a genomic/clinical variant of Porphyromonas gingivalis peptidylarginine deiminase.
Bereta G; Goulas T; Madej M; Bielecka E; Solà M; Potempa J; Gomis-Rüth FX
Protein Sci; 2019 Mar; 28(3):478-486. PubMed ID: 30638292
[TBL] [Abstract][Full Text] [Related]
22. Presence of anti-Porphyromonas gingivalis-peptidylarginine deiminase antibodies in serum from juvenile systemic lupus erythematosus patients.
Figueredo CM; Sete MR; Carlos JC; Lira R; Boström E; Sztajnbok F
Acta Reumatol Port; 2018; 43(3):239-240. PubMed ID: 30414375
[TBL] [Abstract][Full Text] [Related]
23. Extracellular Proteome and Citrullinome of the Oral Pathogen Porphyromonas gingivalis.
Stobernack T; Glasner C; Junker S; Gabarrini G; de Smit M; de Jong A; Otto A; Becher D; van Winkelhoff AJ; van Dijl JM
J Proteome Res; 2016 Dec; 15(12):4532-4543. PubMed ID: 27712078
[TBL] [Abstract][Full Text] [Related]
24. The association between rheumatoid arthritis and periodontitis.
Leech MT; Bartold PM
Best Pract Res Clin Rheumatol; 2015 Apr; 29(2):189-201. PubMed ID: 26362738
[TBL] [Abstract][Full Text] [Related]
25. Periodontal health status, Porphyromonas gingivalis and anti-cyclic citrullinated peptide antibodies among rheumatoid arthritis patients.
Wan Jiun T; Taib H; Majdiah Wan Mohamad W; Mohamad S; Syamimee Wan Ghazali W
Int Immunopharmacol; 2023 Nov; 124(Pt B):110940. PubMed ID: 37722261
[TBL] [Abstract][Full Text] [Related]
26. Peptidylarginine Deiminase 2 Gene Polymorphisms in Subjects with Periodontitis Predispose to Rheumatoid Arthritis.
Massarenti L; Enevold C; Damgaard D; Hansen PR; Frisch M; Ødum N; Jacobsen S; Nielsen CH
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36076933
[TBL] [Abstract][Full Text] [Related]
27. Porphyromonas gingivalis peptidylarginine deiminase substrate specificity.
Abdullah SN; Farmer EA; Spargo L; Logan R; Gully N
Anaerobe; 2013 Oct; 23():102-8. PubMed ID: 23856045
[TBL] [Abstract][Full Text] [Related]
28. Conserved Citrullinating Exoenzymes in Porphyromonas Species.
Gabarrini G; Chlebowicz MA; Vega Quiroz ME; Veloo ACM; Rossen JWA; Harmsen HJM; Laine ML; van Dijl JM; van Winkelhoff AJ
J Dent Res; 2018 May; 97(5):556-562. PubMed ID: 29298553
[TBL] [Abstract][Full Text] [Related]
29. Antibodies against
Svärd A; Kastbom A; Ljungberg KR; Potempa B; Potempa J; Persson GR; Renvert S; Berglund JS; Söderlin MK
Front Immunol; 2023; 14():1183194. PubMed ID: 37325636
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of
Tan SA; Yam HC; Cheong SL; Chow YC; Bok CY; Ho JM; Lee PY; Gunasekaran B
Saudi J Biol Sci; 2022 Apr; 29(4):2573-2581. PubMed ID: 35531186
[No Abstract] [Full Text] [Related]
31. Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and α-enolase: implications for autoimmunity in rheumatoid arthritis.
Wegner N; Wait R; Sroka A; Eick S; Nguyen KA; Lundberg K; Kinloch A; Culshaw S; Potempa J; Venables PJ
Arthritis Rheum; 2010 Sep; 62(9):2662-72. PubMed ID: 20506214
[TBL] [Abstract][Full Text] [Related]
32. Porphyromonas gingivalis facilitates the development and progression of destructive arthritis through its unique bacterial peptidylarginine deiminase (PAD).
Maresz KJ; Hellvard A; Sroka A; Adamowicz K; Bielecka E; Koziel J; Gawron K; Mizgalska D; Marcinska KA; Benedyk M; Pyrc K; Quirke AM; Jonsson R; Alzabin S; Venables PJ; Nguyen KA; Mydel P; Potempa J
PLoS Pathog; 2013 Sep; 9(9):e1003627. PubMed ID: 24068934
[TBL] [Abstract][Full Text] [Related]
33. The
Muñoz-Atienza E; Flak MB; Sirr J; Paramonov NA; Aduse-Opoku J; Pitzalis C; Curtis MA
J Dent Res; 2020 Apr; 99(4):456-462. PubMed ID: 31905316
[TBL] [Abstract][Full Text] [Related]
34. Dropping anchor: attachment of peptidylarginine deiminase via A-LPS to secreted outer membrane vesicles of Porphyromonas gingivalis.
Gabarrini G; Heida R; van Ieperen N; Curtis MA; van Winkelhoff AJ; van Dijl JM
Sci Rep; 2018 Jun; 8(1):8949. PubMed ID: 29895934
[TBL] [Abstract][Full Text] [Related]
35. Impact of Porphyromonas gingivalis Peptidylarginine Deiminase on Bacterial Biofilm Formation, Epithelial Cell Invasion, and Epithelial Cell Transcriptional Landscape.
Aliko A; Kamińska M; Bergum B; Gawron K; Benedyk M; Lamont RJ; Malicki S; Delaleu N; Potempa J; Mydel P
Sci Rep; 2018 Sep; 8(1):14144. PubMed ID: 30237466
[TBL] [Abstract][Full Text] [Related]
36. Increased levels of peptidylarginine deiminase 2 in synovial fluid from anti-CCP-positive rheumatoid arthritis patients: Association with disease activity and inflammatory markers.
Damgaard D; Senolt L; Nielsen CH
Rheumatology (Oxford); 2016 May; 55(5):918-27. PubMed ID: 26880831
[TBL] [Abstract][Full Text] [Related]
37. The role of anti-cyclic citrullinated peptide antibody in periodontal disease.
Ballini A; Tetè S; Scattarella A; Cantore S; Mastrangelo F; Papa F; Nardi GM; Perillo L; Crincoli V; Gherlone E; Grassi FR
Int J Immunopathol Pharmacol; 2010; 23(2):677-81. PubMed ID: 20646367
[TBL] [Abstract][Full Text] [Related]
38. Serum IgG antibodies to peptidylarginine deiminase 4 in rheumatoid arthritis and associations with disease severity.
Halvorsen EH; Pollmann S; Gilboe IM; van der Heijde D; Landewé R; Ødegård S; Kvien TK; Molberg Ø
Ann Rheum Dis; 2008 Mar; 67(3):414-7. PubMed ID: 18006540
[TBL] [Abstract][Full Text] [Related]
39. Association of levels of antibodies against citrullinated cyclic peptides and citrullinated α-enolase in chronic and aggressive periodontitis as a risk factor of Rheumatoid arthritis: a case control study.
Reichert S; Schlumberger W; Dähnrich C; Hornig N; Altermann W; Schaller HG; Schulz S
J Transl Med; 2015 Aug; 13():283. PubMed ID: 26319714
[TBL] [Abstract][Full Text] [Related]
40. The link between periodontal disease and rheumatoid arthritis: an updated review.
Koziel J; Mydel P; Potempa J
Curr Rheumatol Rep; 2014 Mar; 16(3):408. PubMed ID: 24458478
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
